Christine A. Pellizzari

CIK: 0001127430

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

IMNN

Imunon, Inc.

Director

NRSN

NeuroSense Therapeutics Ltd.

Director

TPST

Tempest Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

IMNN
Imunon, Inc.
Jul 31, 2026
Award(A)
Direct
6.9K shares at avg. $1.59$11K
IMNN
Imunon, Inc.
May 22, 2026
Award(A)
Direct
5.6K shares at avg. $2.20$12K
TPST
Tempest Therapeutics, Inc.
Jan 27, 2026
Award(A)
Stock Option (right to buy)
Direct
1.2K shares-
IMNN
Imunon, Inc.
Jan 2, 2026
Award(A)
Stock Option (Right to Buy)
Direct
4.8K shares-
IMNN
Imunon, Inc.
Aug 4, 2025
Award(A)
Direct
2.2K shares at avg. $9.20$21K
IMNN
Imunon, Inc.
Mar 14, 2025
Award(A)
Stock Option (Right to Buy)
Direct
3.8K shares-
IMNN
Imunon, Inc.
Sep 6, 2024
Award(A)
Stock Option (Right to Buy)
Direct
5K shares-

		Type	Shares	Price		Ownership
Jul 31, 2026	IMNN Imunon, Inc.	Award(A)	6,934	$1.59	$11,025	Direct
May 22, 2026	IMNN Imunon, Inc.	Award(A)	5,557	$2.20	$12,225	Direct
Jan 27, 2026	TPST Tempest Therapeutics, Inc.	Award(A) Stock Option (right to buy)	1,230	-	-	Direct
Jan 2, 2026	IMNN Imunon, Inc.	Award(A) Stock Option (Right to Buy)	4,827	-	-	Direct
Aug 4, 2025	IMNN Imunon, Inc.	Award(A)	2,248	$9.20	$20,682	Direct
Mar 14, 2025	IMNN Imunon, Inc.	Award(A) Stock Option (Right to Buy)	3,750	-	-	Direct
Sep 6, 2024	IMNN Imunon, Inc.	Award(A) Stock Option (Right to Buy)	4,964	-	-	Direct

1-7 of 7 transactions

About Pellizzari Christine A

Pellizzari Christine A (SEC CIK 0001127430) files insider reports with the SEC as Director of Imunon, Inc. (IMNN), Director of NeuroSense Therapeutics Ltd. (NRSN) and Director of Tempest Therapeutics, Inc. (TPST).

Signal8 holds 8 ownership filings by Pellizzari Christine A (1 Form 3, 7 Form 4), filed between Sep 10, 2024 and Aug 4, 2026. Those filings report 7 transactions, from Sep 6, 2024 to Jul 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Pellizzari Christine A's filings is in LAWRENCEVILLE, NJ.

Recent filings by Pellizzari Christine A

Jul 31, 2026: Grant or award of IMNN shares (Form 4, code A).
May 22, 2026: Grant or award of IMNN shares (Form 4, code A).
Jan 27, 2026: Grant or award of TPST derivative securities (Form 4, code A).
Jan 2, 2026: Grant or award of IMNN derivative securities (Form 4, code A).
Aug 4, 2025: Grant or award of IMNN shares (Form 4, code A).

Other insiders filing for Imunon, Inc. (IMNN)

Tardugno Michael H, Executive Chairman of Board
Lindborg Stacy, President and CEO
Faller Douglas Vincent, Chief Medical Officer
Eylward Susan, General Counsel and Corp Sec
Dentzer James E, Director
Fritz Frederick J., Director

How to read Form 4 transaction codes